This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-outlook: Archive
TKO Group Holdings (TKO) Reports Q4 Loss, Beats Revenue Estimates
by Zacks Equity Research
TKO Group (TKO) delivered earnings and revenue surprises of -157.97% and +1.37%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
TKONegative Net Change CURIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Xencor (XNCR) delivered earnings and revenue surprises of +86.00% and +30.62%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
XNCRPositive Net Change RIGLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
VICI Properties Inc. (VICI) Q4 FFO Meet Estimates
by Zacks Equity Research
VICI Properties (VICI) delivered FFO and revenue surprises of 0.00% and -0.28%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
VICINegative Net Change SBACNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Veracyte (VCYT) delivered earnings and revenue surprises of +30.06% and +1.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
VCYTPositive Net Change LUCDNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Universal Health Services (UHS) Lags Q4 Earnings Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of -0.63% and +0.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
UHSPositive Net Change BTMDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
The Trade Desk (TTD) Meets Q4 Earnings Estimates
by Zacks Equity Research
The Trade Desk (TTD) delivered earnings and revenue surprises of +0.37% and +0.58%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
TTDPositive Net Change EBNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Xperi (XPER) Lags Q4 Earnings Estimates
by Zacks Equity Research
Xperi (XPER) delivered earnings and revenue surprises of -17.24% and +0.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
XPERPositive Net Change CRCTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of -0.52% and -0.27%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
APositive Net Change XGNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Arcutis Biotherapeutics (ARQT) delivered earnings and revenue surprises of +290.39% and +11.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ARQTPositive Net Change TRDAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ARKO Corp. (ARKO) Reports Break-Even Earnings for Q4
by Zacks Equity Research
ARKO (ARKO) delivered earnings and revenue surprises of +100.00% and -0.99%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ARKONegative Net Change DNUTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank